In this project Dr Shamima Rahman at the University College London Institute of Child Health aims to identify new genetic changes causing mitochondrial diseases.
In this project Dr Shamima Rahman at the University College London Institute of Child Health aims to identify new genetic changes causing mitochondrial diseases.
In this project Dr Shamima Rahman at the University College London Institute of Child Health aims to identify new genetic changes causing mitochondrial diseases.
In this project Professor Wells and his PhD student will investigate ways to improve the delivery of molecular patches so they can reach all the muscles more easily.
In this project Professor Wells and his PhD student will investigate ways to improve the delivery of molecular patches so they can reach all the muscles more easily.
In this project Professor Wells and his PhD student will investigate ways to improve the delivery of molecular patches so they can reach all the muscles more easily.
In this project, Prof. Thomas Gillingwater will test whether a very important, but often overlooked, type of cell that supports motor neurons contribute to the onset and severity of spinal muscular atrophy.
In this project, Prof. Thomas Gillingwater will test whether a very important, but often overlooked, type of cell that supports motor neurons contribute to the onset and severity of spinal muscular atrophy.
In this project, Prof. Thomas Gillingwater will test whether a very important, but often overlooked, type of cell that supports motor neurons contribute to the onset and severity of spinal muscular atrophy.
Prof Kate Bushby will supervise this PhD project which aims to increase our understanding of the underlying cause of limb girdle muscular dystrophy types 2B and 2L.
Prof Kate Bushby will supervise this PhD project which aims to increase our understanding of the underlying cause of limb girdle muscular dystrophy types 2B and 2L.
Prof Kate Bushby will supervise this PhD project which aims to increase our understanding of the underlying cause of limb girdle muscular dystrophy types 2B and 2L.
Prof Muntoni has gathered important information about the genes that are known to be involved in the dystroglycanopathies but also on new genes that are now thought to be involved.
Prof Muntoni has gathered important information about the genes that are known to be involved in the dystroglycanopathies but also on new genes that are now thought to be involved.
Prof Muntoni has gathered important information about the genes that are known to be involved in the dystroglycanopathies but also on new genes that are now thought to be involved.
Prof Beeson and his colleagues aim to study the drug ephedrine to find out why it is effective for people with a type of congenital myasthenic syndrome (CMS) and if ephedrine could be useful for some people with myasthenia gravis.
Prof Beeson and his colleagues aim to study the drug ephedrine to find out why it is effective for people with a type of congenital myasthenic syndrome (CMS) and if ephedrine could be useful for some people with myasthenia gravis.
Prof Beeson and his colleagues aim to study the drug ephedrine to find out why it is effective for people with a type of congenital myasthenic syndrome (CMS) and if ephedrine could be useful for some people with myasthenia gravis.
Professor Hanna and his PhD student will aim to look for new genes that might be associated with periodic paralysis and the myotonias.
Professor Hanna and his PhD student will aim to look for new genes that might be associated with periodic paralysis and the myotonias.
Professor Hanna and his PhD student will aim to look for new genes that might be associated with periodic paralysis and the myotonias.
Prof Straub has used MRI to gather vital information about how to monitor the changes in the muscles of boys with Duchenne muscular dystrophy for clinical trials.
Prof Straub has used MRI to gather vital information about how to monitor the changes in the muscles of boys with Duchenne muscular dystrophy for clinical trials.
Prof Straub has used MRI to gather vital information about how to monitor the changes in the muscles of boys with Duchenne muscular dystrophy for clinical trials.
Prof Bushby at the University of Newcastle will investigate why a reduction or absence of the dysferlin protein leads to muscle damage in the muscle diseases known as dysferlinopathies.
Prof Bushby at the University of Newcastle will investigate why a reduction or absence of the dysferlin protein leads to muscle damage in the muscle diseases known as dysferlinopathies.
Prof Bushby at the University of Newcastle will investigate why a reduction or absence of the dysferlin protein leads to muscle damage in the muscle diseases known as dysferlinopathies.
Dr Judith Sleeman at the University of St Andrews is aiming to gain a better understanding of the biological changes that occur in the nuclei of cells from people with myotonic dystrophy type 1. This knowledge will help to direct future research into potential treatments.
Dr Judith Sleeman at the University of St Andrews is aiming to gain a better understanding of the biological changes that occur in the nuclei of cells from people with myotonic dystrophy type 1. This knowledge will help to direct future research into potential treatments.
Dr Judith Sleeman at the University of St Andrews is aiming to gain a better understanding of the biological changes that occur in the nuclei of cells from people with myotonic dystrophy type 1. This knowledge will help to direct future research into potential treatments.
Subscribe to